UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Consent Statement Pursuant to Section
14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant 
Filed by a Party other than the Registrant 
Check the appropriate box:
Preliminary Consent Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Consent Statement
Definitive Additional Materials
Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
CRITICARE SYSTEMS, INC.
________________________________________________________________________________________________________
(Name of Registrant as Specified in Its Charter)
BLUELINE PARTNERS, L.L.C.
________________________________________________________________________________________________________
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of filing fee (Check the
appropriate box):
No fee required.
Fee computed on table below per
Exchange Act Rules 14a-6(i)(1) and 0-11.
| (1) |
|
Title of each class of securities to which transaction applies: |
| |
|
____________________________________________________________________________ |
| (2) |
|
Aggregate number of securities to which transaction applies: |
| |
|
____________________________________________________________________________ |
| (3) |
|
Per unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is
calculated and state how it was determined): |
| |
|
____________________________________________________________________________ |
| (4) |
|
Proposed maximum aggregate value of transaction: |
| |
|
____________________________________________________________________________ |
| |
|
____________________________________________________________________________ |
Fee paid previously with
preliminary materials.
Check box if any part of the fee
is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which
the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.
| (1) |
|
Amount Previously Paid: |
| |
|
____________________________________________________________________________ |
| (2) |
|
Form, Schedule or Registration Statement No.: |
| |
|
____________________________________________________________________________ |
| |
|
____________________________________________________________________________ |
| |
|
____________________________________________________________________________ |
BlueLine Partners,
L.L.C. has established the following internet homepage at http://www.bluelinepartners.com/stories/storyReader$58
to provide information regarding the consent solicitation:
CRITICARE STOCKHOLDER
CONSENT
This is the page where BlueLine will
make available information relating to its efforts to re-form Criticare’s board of
directors and elect a new majority of directors who are independent of management and have
the experience and commitment necessary to properly represent the interests of the
company’s stockholders:
| |
• |
BlueLine press release announcing consent solicitation |
| |
• |
BlueLine letter to stockholders explaining need for consent solicitation |
| |
• |
Consent statement filed with the Securities and Exchange Commission |
| |
• |
Consent card and instructions (this is the form used to vote shares) |
| |
• |
Instructions on how to vote your shares |
| |
• |
BlueLine's August 22, 2006 SEC filing announcing its intentions to seek stockholder consent |
| |
• |
Link to SEC EDGAR site with all Criticare filings |
If you have any questions about
executing your consent or require assistance, please contact:
BlueLine Partners, L.L.C.
4115 Blackhawk Plaza Circle, Suite 100
Danville, California 94506
Telephone: (925) 648-2085
Facsimile: (925) 648-2086
Attention: Scott A. Shuda
____________________________
©Copyright 2006
BlueLine Partners
Investors: Login
BlueLine Home
Investment Approach
Recent Investments
BlueLine’s Team
Contact BlueLine
Criticare Stockholder
Consent
Recent News
|
|
| 9/12/06 |
|
|
BlueLine Commences Criticare |
|
|
| | | |
Proxy Solicitation | | |
| | | |
| 8/30/06 | | |
AXS-One and BlueLine | | |
| | | |
Featured by Dow Jones | | |
| | | |
| 8/28/06 | | |
BlueLine Files Preliminary Proxy | | |
| | | |
for Criticare | | |
| | | |
| 8/22/06 | | |
Blue Files New Criticare 13D | | |
| | | |
| 7/26/06 | | |
BlueLine Files New | | |
| | | |
Urologix 13D | | |
| | | |
| 7/07/06 | | |
BlueLine Files 13D | | |
| | | |
for AXS-One | | |
| | | |
| 7/05/06 | | |
BlueLine Helps Enpath | | |
| | | |
Recruit New CFO | | |
| | | |
| 7/05/06 | | |
BlueLine Participates in | | |
| | | |
Incentra Financing | | |